Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Quintessence Int ; 53(9): 782-789, 2022 Sep 16.
Article in English | MEDLINE | ID: mdl-35726548

ABSTRACT

OBJECTIVE: To evaluate the effects of zinc oxide-eugenol, calcium hydroxide, and mineral trioxide aggregate as base materials on the clinical and radiographic success of ferric sulfate pulpotomies in primary molars. METHOD AND MATERIALS: Following hemostasis with 15.5% ferric sulfate, 105 teeth were randomly allocated to three groups: Group 1, zinc oxide-eugenol; Group 2, calcium hydroxide; and Group 3, mineral trioxide aggregate. All teeth were restored with stainless-steel crowns. Clinical and radiographic examinations were conducted at 6, 12, 18, and 24 months. RESULTS: After 24 months, clinical success rates for Groups 1 to 3 were 97.1% (34/35 teeth), 94.2% (33/35 teeth), and 97.1% (34/35 teeth), respectively (P > .05). Radiographic success rates were 65.7% (23/35 teeth), 65.7% (23/35 teeth), and 77.1% (27/35 teeth), respectively (P > .05). Internal resorption was the most observed radiographic finding (15/105 teeth). CONCLUSIONS: The choice of zinc oxide-eugenol, calcium hydroxide, and mineral trioxide aggregate, as base materials, did not affect the clinical and radiographic success of ferric sulfate pulpotomies in primary teeth.


Subject(s)
Pulpotomy , Zinc Oxide , Calcium Compounds/therapeutic use , Calcium Hydroxide/pharmacology , Calcium Hydroxide/therapeutic use , Drug Combinations , Eugenol/pharmacology , Ferric Compounds , Humans , Molar/surgery , Oxides/therapeutic use , Pulpotomy/methods , Silicates/therapeutic use , Steel/pharmacology , Tooth, Deciduous , Treatment Outcome , Zinc Oxide/pharmacology , Zinc Oxide-Eugenol Cement/pharmacology , Zinc Oxide-Eugenol Cement/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...